12/10/2019SAMR Solicits Public Comments on the Provisions for Registration of Dr...

12/10/2019CStone's anti-PD-L1 antibody Demonstrates Promising Antitumor Activity

12/10/2019China Cuts Prices For 70 More Drugs After Talks with Pharmaceutical Fi...

12/9/2019PingAn Good Doctor and Merck Sign Agreement to Explore Integrated Heal...

12/9/2019Samsung Bioepis Approved to Initiate Phase 3 Trial of Trastuzumab Bios...

12/9/2019Joinn Bio Raises $60M in Round A Financing

12/6/2019NHSA Issues New Policy for Drug Price Regulation

12/6/2019Recent Executive Moves

12/6/2019Innovent Announces First Patient Dosed in Phase I Trial of Anti-LAG-3 ...

12/5/2019Amgen's IND for Osteoporosis Drug Romosozumab Approved in China

12/5/2019XiAn Janssen's Application for 2nd Indication of Erleada Accepted in C...

12/5/2019Interpace Bio Expands Strategic Partnership with Genecast in China

12/5/2019AstraZeneca-Merck Lynparza Approved in China for Ovarian Cancer

12/4/2019Bio-Thera's IND for Biosimilar of Stelara (Ustekinumab) Approved in Ch...

12/4/2019Yaobili Set to Change China's Pharmaceutical Industry with New Model

12/4/2019Additional Indication for Lenvima (Lenvatinib) For Differentiated Thyr...

12/3/2019Why Chinese Biotech Companies Are Not For Faint-Hearted Investors

12/3/2019New Round of Negotiation for NRDL Access Begins as Big Pharma Bosses L...

12/3/2019NHC Sets Six Major New Goals to Keep AIDS/AIDS Under Control

12/3/2019Biotech Startup Alphamab to Raise $230M in HK IPO

12/3/2019EOC Pharma Raised $71M in Series C Round

12/3/2019GI Innovation Out-licenses Immunotherapy Drug Candidate to Simcere Pha...

12/3/2019China Gives Merck, BMS Cold Shoulder on Reimbursement List as PD-1 Bat...

12/2/2019Expanded 4+7 Trial to Add 35 More Drug Products for National Level Pur...

12/2/2019State Council Issues New Centralized Drug Procurement Purchase and Use...

12/2/2019NMPA Announces Withdrawal of Additional 68 Certificate Requirements to...

12/2/2019NMPA and NHC Jointly Issues the Provisions for Drug Clinical Trial Ins...

12/2/2019NMPA Issues Notice on Relevant Matters for Implementation of the Drug ...

11/29/2019Recent Executive Moves

11/29/2019NMPA Approves Chipscreen's Chidamide (Epidaza) for Breast Cancer

Page:271/789 Total number of articles:23668: [First][<<] [269] [270] [271] [272] [273] [>>] [End]